0001437749-13-013602.txt : 20131030
0001437749-13-013602.hdr.sgml : 20131030
20131030132038
ACCESSION NUMBER: 0001437749-13-013602
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131028
FILED AS OF DATE: 20131030
DATE AS OF CHANGE: 20131030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPAX LABORATORIES INC
CENTRAL INDEX KEY: 0001003642
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 650403311
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
BUSINESS PHONE: 510-240-6000
MAIL ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HSU LARRY
CENTRAL INDEX KEY: 0001245199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34263
FILM NUMBER: 131178636
MAIL ADDRESS:
STREET 1: C/O IMPAX LABORATORIES, INC.
STREET 2: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
4
1
rdgdoc.xml
FORM 4
X0306
4
2013-10-28
0001003642
IMPAX LABORATORIES INC
IPXL
0001245199
HSU LARRY
C/O IMPAX LABORATORIES, INC.
30831 HUNTWOOD AVENUE
HAYWARD
CA
94544
1
1
President and CEO
Common Stock
2013-10-28
4
F
0
1827
20.61
D
146759
I
By Spouse
Common Stock
2013-10-29
4
F
0
1827
20.68
D
144932
I
By Spouse
Common Stock
677954
D
Common Stock
2309658
I
By The Hsu Family Trust
These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy the payroll tax withholding obligations of Dr. Ann Hsu (the Reporting Person's spouse). Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy the payroll tax withholding obligations of Dr. Ann Hsu (the Reporting Person's spouse). Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Mark A. Schlossberg, by Power of Attorney
2013-10-30